hibiscrub 40 mg/ ml
mölnlycke health care ab (1) - klorheksidindiglukonat - liniment, oppløsning - 40 mg/ ml
loceryl 5 % w/v
galderma nordic ab - amorolfinhydroklorid - medisinsk neglelakk - 5 % w/v
remifemin -
schaper & brümmer gmbh & co kg - klaseormedruerot - tablett
dasatinib accord
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastiske midler - dasatinib accord is indicated for the treatment of adult patients with:• ph+ acute lymphoblastic leukaemia (all) with resistance or intolerance to prior therapy. dasatinib accord is indicated for the treatment of paediatric patients with:• newly diagnosed ph+ all in combination with chemotherapy.
vyndaqel
pfizer europe ma eeig - tafamidis - amyloidosis - andre nervesystemet narkotika - vyndaqel er indisert for behandling av transthyretinamyloidose hos voksne pasienter med fase 1-symptomatisk polyneuropati for å forsinke perifer neurologisk nedsatt funksjonsevne.
apresolin 25 mg
amdipharm ltd - hydralazinhydroklorid - tablett, drasjert - 25 mg
betnovat 1 mg/ ml
glaxosmithkline as - betametasonvalerat - liniment, oppløsning - 1 mg/ ml
corsodyl 1 %
haleon denmark aps - klorheksidindiglukonat - dentalgel - 1 %
elocon 0.1 %
n.v. organon - kloosterstraat - mometasonfuroat - krem - 0.1 %